The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.

Autor: Casaburi, Richard, Briggs Jr., Dick D., Donohue, James F., Serby, Charles W., Menjoge, Shailendra S., Witek Jr., Theodore J., Casaburi, R, Briggs, D D Jr, Donohue, J F, Serby, C W, Menjoge, S S, Witek, T J Jr

Publikováno v: CHEST; Nov2000, Vol. 118 Issue 5, p1294-1302, 9p

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

Autor: Casaburi R; Harbor-UCLA Research and Education Institute, Torrance, CA 90502, USA., Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr

Publikováno v: The European respiratory journal [Eur Respir J] 2002 Feb; Vol. 19 (2), pp. 217-24.

Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease.

Autor: Littner MR; Sepulveda Ambulatory Care and Nursing Home, Veterans Administration Greater Los Angeles Healthcare System, Sepulveda, CA, USA., Ilowite JS, Tashkin DP, Friedman M, Serby CW, Menjoge SS, Witek TJ Jr

Publikováno v: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2000 Apr; Vol. 161 (4 Pt 1), pp. 1136-42.

Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.

Autor: Friedman M; Section of Pulmonary Disease, Critical Care Medicine, and Environmental Medicine, Tulane University Medical Center, School of Medicine, New Orleans, LA, USA., Serby CW, Menjoge SS, Wilson JD, Hilleman DE, Witek TJ Jr

Publikováno v: Chest [Chest] 1999 Mar; Vol. 115 (3), pp. 635-41.

Fenoterol in exercise-induced asthma. Effect of dose on efficacy and duration of action.

Autor: König P, Hordvik NL, Serby CW

Publikováno v: Chest [Chest] 1984 Apr; Vol. 85 (4), pp. 462-4.